Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature
GastroenterologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- PloS one
- Publicado em
- 17 jun 2021
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature
Sarah Peisl, Claudia Mellenthin, Lucie Vignot, Carmen Gonelle-Gispert, Leo Buhler, Bernhard Egger
Descritores MeSH
- STAT3 Transcription Factor
- Signal Transduction
- Pancreatic Neoplasms
- Carcinoma, Pancreatic Ductal
- Cytokine Receptor gp130
- Animals
- Molecular Targeted Therapy
- Antineoplastic Agents
- Humans
Veja também
Estudos relacionados
- Efficacy and safety signals from early-phase studies of KRAS inhibition in pancreatic cancer
- Necroptosis in pancreatic cancer: Molecular mechanisms and therapeutic implications
- High Intratumoral PROS1 Expression Correlates with Improved Survival and Is Associated with Suppressed Oncogenic Signaling in Pancreatic Ductal Adenocarcinoma
- β-Arrestin and receptor tyrosine kinases in non-small cell lung cancer: A comprehensive review